Early morning hydroxyproline excretion in patients with breast cancer.
The hydroxyproline/creatinine excretion ratios have been measured in half-hour fasting morning urine specimens from breast cancer patients and compared with corresponding values measured in 24 hour urine collections. Both parameters show a close correlation. The value of the half-hour test in predicting the presence of early bone metastases, in monitoring the response of patients to therapy and in eliminating unwanted effects of dietary Hydroxyproline intake are discussed.
D001859:Bone Neoplasms / Q000175:diagnosis / Q000652:urine; D001943:Breast Neoplasms / Q000652:urine*; D003401:Creatine / Q000652:urine; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000652:urine*; D009362:Neoplasm Metastasis; D013997:Time Factors
D003401:Creatine; D006909:Hydroxyproline